Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2003 August;55(4) > Minerva Ginecologica 2003 August;55(4):327-32

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Ginecologica 2003 August;55(4):327-32

Copyright © 2003 EDIZIONI MINERVA MEDICA

language: Italian

Tumor markers in epithelial ovarian cancer

Di Cocco B., Calabretta F., Alghisi F., Salesi N., Bossone G.


PDF


Many circulating markers are already in clinical practice and in experimental use for the diagnosis, therapeutic monitoring, and in the follow-up of ovarian cancer. The cancer antigen-125 (CA-125) has shown to be useful in epithelial ovarian cancer, but its specificity is too low for the test to be used as a primary screening technique in early stage and particularly in premenopausal women. In the last few years, several studies have focused on using the serial measurement of complementary serum mar-kers to improve the positive predictive value and diagnostic accuracy. The main problem is that the different cellular lines express these markers in a very variable way.

top of page